Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
BTB Emulsions AB is a Swedish SME founded in 2016 and a subsidiary of BTB Pharma AB. Its core product, POWER-Kit™, is designed for preparing emulsions with Freund’s incomplete/complete adjuvant and other oil-based adjuvants. The goal is to replace the traditional 2-syringe method and improve consistency in emulsion quality for animal experiments. Strictly speaking, it is not SaaS or enterprise software, but rather a life-science lab equipment and methodology solution.
POWER-Kit™ uses components such as the POWER receptacle together with a homogenizer to prepare emulsions from any oil-based adjuvant and antigen. According to the FAQ, it is suitable for antigen-specific proliferation assays; autoimmune models such as EAE, CIA, EAU, and MG; cancer immunotherapy protein/peptide experiments; DTH experiments; and monoclonal and polyclonal antibody production. Its stated advantages include high quality, speed, reliability, ease of use, reduced material loss, and avoidance of the repetitive strain that may be caused by the two-syringe method. At present, a single receptacle supports a maximum final emulsion volume of about 8ml. When the volume is below 4ml, the emulsion may be thinner, although the text says it can still induce an immune response.
The website only states that its business model is selling POWER-Kit™, with an initial focus on preclinical research and veterinary markets. It does not disclose specific pricing, plans, payment methods, or trial policies. Since the product is not software, the pages do not include information about team permissions, third-party integrations, APIs, cloud deployment, or self-hosting. On compliance, it only mentions that entering the human medical market in the future would require consideration of CE marking and other regulatory compliance requirements. Related commercial and marketing plans are still under development.
Its strengths are clear positioning: it addresses unstable lab emulsion preparation, material waste, and repetitive-operation issues, while also providing a relatively specific FAQ and microscopy-based methods for checking emulsion quality. The drawbacks are limited transparency, with key procurement information such as pricing, delivery, after-sales support, and certification progress missing, and the currently visible specifications appear limited to a single setup. It is better suited to laboratories working on animal models, autoimmunity, vaccines, antibodies, or early-stage immunotherapy research, rather than as an enterprise software purchase.
The website does not provide information on China-region sales, payment, or local agents, and China accessibility cannot be determined from the available text. For procurement within China, buyers would need to further confirm cross-border shipping, payment, consumable supply, and after-sales support. Alternatives include the traditional two-syringe method, as well as other laboratory homogenizer or emulsification equipment solutions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on btbemulsions.com official site.
btbemulsions.com is an Sweden Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach btbemulsions.com directly.